Skip to content

Monday, Nov. 4, 2024

Has Tammy Baldwin taken steps to lower prescription drug prices?


yes

U.S. Sen. Tammy Baldwin, D-Wisconsin, has backed efforts to reduce prescription drug prices:

Cosponsored 2024 legislation to cap annual out-of-pocket costs at $2,000 per individual and $4,000 per family for people with private health insurance. No action has been taken.

Sent letters in January 2024 along with other senators to drug manufacturers demanding information on “exorbitant” asthma inhalers prices.

Sponsored 2023 legislation to require drug manufacturers to provide details of and justification for certain price increases. No action has been taken.

Supported the Inflation Reduction Act, which became law in 2022. It requires Medicare to negotiate the price of certain drugs.

Baldwin’s challenger in the Nov. 5, 2024, election, Republican Eric Hovde, stated that Baldwin “always talks about, ‘I’m going to lower drug prices.’ She’s done nothing on that.”

Average U.S. prescription drug prices are 2.78 times higher than in 33 other nations, the RAND think tank reported in February.

See a full discussion of this at Wisconsin Watch

This fact brief is responsive to conversations such as this one.

About fact briefs

Fact briefs are bite-sized, well-sourced explanations that offer clear "yes" or "no" answers to questions, confusions, and unsupported claims circulating online. They rely on publicly available data and documents, often from the original source. Fact briefs are written and published by Gigafact contributor publications.

See all fact briefs

Wisconsin Watch, the news arm of the nonpartisan, nonprofit Wisconsin Center for Investigative Journalism, increases the quality and quantity of investigative reporting in Wisconsin, while training current and future investigative journalists. Its work fosters an informed citizenry and strengthens democracy.

Learn More

Be a Friend of facts

Help us fund more great fact briefs like this one.